Friday, May 09, 2025

AdvocateHealthyu

advocatehealthyu.com
AdvocateHealthyu
advocatehealthyu.com
  • Health News
  • Personal Health
  • Health Problems
  • Medications
  • Family Health
  • Kids Health
  • Beauty & Balance

Home » Oncology

Cancer patients on remote monitoring program less likely to require hospitalization for COVID-19

A study by researchers at Mayo Clinic Cancer Center has found that cancer patients diagnosed…

View More Cancer patients on remote monitoring program less likely to require hospitalization for COVID-19

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack…

View More CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Future lung cancer screening strategies should address equity, implementation issues, say experts

Calling the U.S. Preventive Services Task Force's newly released recommendation statement to expand eligibility for…

View More Future lung cancer screening strategies should address equity, implementation issues, say experts

Researchers have found a molecular explanation to a longstanding enigma in viral oncology

The oncogenic herpesvirus (HHV8 or KSHV) causes a cancer known as Kaposi’s sarcoma. An international…

View More Researchers have found a molecular explanation to a longstanding enigma in viral oncology

Proteus Digital Health Launches Digital Oncology Medicines to Improve Patient Outcomes

January 17, 2019 – REDWOOD CITY, Calif. and MINNEAPOLIS, Minn. – Proteus Digital Health®, Inc.,…

View More Proteus Digital Health Launches Digital Oncology Medicines to Improve Patient Outcomes

Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305

STAMFORD, Conn., Dec. 21, 2018 (GLOBE NEWSWIRE) — Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company…

View More Loxo Oncology Announces Initiation of Phase 1/2 Clinical Trial for Highly Selective, Non-Covalent BTK Inhibitor, LOXO-305

On-the-fly, Talina, on-the-fly: How parents, her little daughter at home, accompany in death

Perhaps the Hardest thing to create parents: to have A child in love. Because anything…

View More On-the-fly, Talina, on-the-fly: How parents, her little daughter at home, accompany in death
Personal Health

DRILL These Must Know Dos and Dont’s If You Want Healthy Skin

Everybody desires great skin. But flawless and blemish-free skin is worth a lot. Everyone wants…

Paxlovid reduces risk of long-term health problems, death from COVID-19

The risk of long-term health problems, hospitalization and death after a COVID-19 infection diminishes among…

A $30 Million Gift to Build an Addiction Treatment Center. Then Staffers Had to Run It.

DECATUR, Ill. — The question came out of the blue, or so it seemed to…

Medications

FDA Approves Suflave

FDA Approves Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride)…

FDA Approves Abilify Asimtufii

FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of…

High Inflation and Housing Costs Force Many Americans to Delay Needed Care

At a health-screening event in Sarasota, Florida, people gathered in a parking lot and waited…

Health News

UKHSA and ONS publish latest Winter CIS data

Reviewed The Winter CIS was launched jointly by the UK Health Security Agency (UKHSA) and…

Brain lesions in former football players linked to vascular, brain changes

Signs of injury to the brain’s white matter called white matter hyperintensities, as seen on…

French pharma firm ordered to pay millions over deadly diabetes drug

A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460…

AdvocateHealthyu | © Copyright All right reserved
Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok